Used in research and development of pharmaceutical formulations targeting central nervous system disorders. Shows potential in enhancing drug delivery due to improved solubility and controlled release properties. Investigated for its role in treating psychiatric conditions such as schizophrenia and bipolar disorder by modulating dopamine and serotonin receptors. Also explored for better pharmacokinetic profiles compared to parent compounds. Not approved for clinical use; currently limited to laboratory and preclinical studies.